Skip to main navigation
Altimmune Website
Menu

    Nav About Us

  • About Us
    • Company Overview
    • Executive Committee
    • Board of Directors
    • Scientific Advisory Boards
    • Partnerships
    • Serious Liver Diseases
  • Nav Pipeline

  • Pipeline
    • Our Pipeline
    • Pemvidutide
  • Nav IR

  • Investors
    • Overview
    • Press Releases
    • In The News
    • Events and Presentations
      • Events and Presentations
      • Scientific Posters and Presentations
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
      • Investment Calculator
    • Analyst Coverage
    • Governance
      • Documents & Charters
      • Executive Committee
      • Board of Directors
      • Committee Composition
    • Financials
      • SEC Filings
    • Investor Resources
      • Investor FAQs
      • IR Contact
      • Email Alerts
  • Nav Clinical Trials

  • Clinical Trials
    • OVERVIEW
    • Expanded Access policy
  • Nav Partnerships

  • Careers
  • Nav Contact

  • Contact Us

    Events
    and Presentations

    Menu

    Tabs Events and Presentations

    • Events and Presentations
    • Scientific Posters and Presentations

    Events and Presentations

    Corporate Presentations
    Corporate Presentation August 2026
    RECLAIM Phase 2 Trial in AUD Topline Results Presentation
    Pemvidutide IMPACT Phase 2b 48-Week Data Readout Presentation
    Upcoming Events
    Sep 30, 2026 at 10:30 AM EDT
    Stifel 2026 Virtual Cardiometabolic Forum
    Click here for webcast
    Add to Outlook
    Add to Google Calendar
    Past Events
    Sep 10, 2026 at 9:30 AM EDT
    Wells Fargo 21st Annual Healthcare Conference
    Click here for webcast
    Aug 12, 2026 at 8:30 AM EDT
    Altimmune Second Quarter 2026 Earnings Conference Call
    Click here for webcast
    Jul 28, 2026 at 8:00 AM EDT
    RECLAIM Phase 2 Trial in AUD Topline Results Conference Call
    Click here for webcast
    RECLAIM Phase 2 Trial in AUD Topline Results Presentation 1.7 MB
     

    Investor Contact

    Email: ir@altimmune.com

     

    Email Alerts

    Automatically receive Altimmune, Inc. financial information by e-mail

    Subscribe
    altimmune logo

    910 Clopper Road
    Suite 201-S
    Gaithersburg, MD 20878
    (240) 654-1450

    Nav ALTIMMUNE

    Altimmune

    • About Us
    • Serious Liver Diseases
    • Clinical Trials
    • Partnerships
    • Careers
    • Contact Us
    • Expanded Access Policy
    • Terms & Conditions
    • Privacy Policy

    Nav Pipeline

    Pipeline

    • Our Pipeline
    • Pemvidutide

    Nav IR

    Investors

    • Overview
    • Press Releases
    • In The News
    • Events and Presentations
    • Stock Information
    • Analyst Coverage
    • Governance
    • Financials
    • Investor Resources

    © 2026 Altimmune. All rights reserved.

    Social

      Nav About Us

    • About Us
      • Company Overview
      • Executive Committee
      • Board of Directors
      • Scientific Advisory Boards
      • Partnerships
      • Serious Liver Diseases
    • Nav Pipeline

    • Pipeline
      • Our Pipeline
      • Pemvidutide
    • Nav IR

    • Investors
      • Overview
      • Press Releases
      • In The News
      • Events and Presentations
        • Events and Presentations
        • Scientific Posters and Presentations
      • Stock Information
        • Stock Quote & Chart
        • Historical Price Lookup
        • Investment Calculator
      • Analyst Coverage
      • Governance
        • Documents & Charters
        • Executive Committee
        • Board of Directors
        • Committee Composition
      • Financials
        • SEC Filings
      • Investor Resources
        • Investor FAQs
        • IR Contact
        • Email Alerts
    • Nav Clinical Trials

    • Clinical Trials
      • OVERVIEW
      • Expanded Access policy
    • Nav Partnerships

    • Careers
    • Nav Contact

    • Contact Us